Baystate Wealth Management LLC Caribou Biosciences, Inc. Transaction History
Baystate Wealth Management LLC
- $1.36 Billion
- Q4 2023
Shares
1 transactions
Others Institutions Holding CRBU
# of Institutions
138Shares Held
54.4MCall Options Held
21.2KPut Options Held
96.4K-
Black Rock Inc. New York, NY6.95MShares$6.53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.57MShares$4.29 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.88MShares$3.64 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.75MShares$2.58 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.5MShares$2.35 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $57.2M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...